Aspiriant LLC’s Vanguard Mega Cap Growth ETF MGK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$954K Sell
12,985
-1,425
-10% -$112K 0.03% 157
2025
Q4
$1.19M Buy
14,410
+10,840
+304% +$890K 0.03% 151
2025
Q3
$287K Hold
3,570
0.01% 256
2025
Q2
$262K Hold
3,570
0.01% 273
2025
Q1
$221K Hold
3,570
0.01% 278
2024
Q4
$245K Hold
3,570
0.01% 257
2024
Q3
$230K Hold
3,570
0.01% 262
2024
Q2
$224K Hold
3,570
0.01% 264
2024
Q1
$205K Buy
+3,570
New +$197K 0.01% 307
2019
Q1
Sell
-11,500
Closed -$246K 238
2018
Q4
$246K Hold
11,500
0.02% 203
2018
Q3
$295K Hold
11,500
0.03% 196
2018
Q2
$274K Sell
11,500
-46,375
-80% -$1.08M 0.02% 211
2018
Q1
$1.3M Buy
+57,875
New +$1.34M 0.11% 92
2017
Q4
Sell
-57,875
Closed -$1.21M 136
2017
Q3
$1.21M Hold
57,875
0.1% 97
2017
Q2
$1.16M Sell
57,875
-12,000
-17% -$238K 0.1% 103
2017
Q1
$1.34M Buy
69,875
+23,500
+51% +$436K 0.11% 102
2016
Q4
$808K Sell
46,375
-51,875
-53% -$899K 0.07% 118
2016
Q3
$1.72M Buy
+98,250
New +$1.71M 0.17% 77

Other funds holding MGK

Aspiriant LLC's MGK Position: Q1 2026 in Review

Aspiriant LLC reduced its Vanguard Mega Cap Growth ETF (MGK) stake by 9.9% in Q1 2026, selling an estimated $112K and leaving 12,985 shares worth $954K. The position accounts for 0.03% of the portfolio, ranked #157.

Aspiriant LLC first reported a position in MGK in Q3 2016 and has held it in 18 quarters since. The position peaked at $1.72M in Q3 2016. 954 funds tracked by Wall St. Rank hold MGK as of Q1 2026.

  • Aspiriant LLC held 12,985 shares of Vanguard Mega Cap Growth ETF worth $954K as of Q1 2026.
  • Aspiriant LLC sold 1,425 Vanguard Mega Cap Growth ETF shares in Q1 2026, an estimated $112K.
  • Vanguard Mega Cap Growth ETF made up 0.03% of Aspiriant LLC's portfolio in Q1 2026, its #157 holding.
  • Aspiriant LLC first reported a position in Vanguard Mega Cap Growth ETF in Q3 2016 and has held it in 18 quarters since.
  • Aspiriant LLC's Vanguard Mega Cap Growth ETF position peaked at $1.72M in Q3 2016.
  • 954 funds tracked by Wall St. Rank held Vanguard Mega Cap Growth ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.